1. Ye H., Wu J.M., Yang Y.S., Chen K.X., Ji R.Y. (2002): Antibacterial activities of the derivatives -YH54 and YH57 of levofloxacin in vitro. Chin. Pharmacol. Bull., 18: 112–3.
2. Hong J.W., Hu C.Q. (2004): Determination of enantiomeric impurity of antofloxacin in hydrochloride by high performance liquid chromatography. Chin. J. Antibiot., 29: 349–353.
3. Mayer A. (1996): Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharmacol., 24: 449.
4. Reginald F.F. (2004): Probing the world of cytochrome P450 enzymes. Mol. Interventions., 4: 157–162.
5. Siwaporn C., Anne N.N., Steven L. al. (2003): Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, iV-acetyltransferase-2, and xanthineoxidase activities with the ‘Cooperstown 5+1 cocktail’. Clin. Pharmacol Ther., 74: 437–447.